Table 3.
Treatment | Hb (mg/ml) | P50 (mmHg) | pH | K+ (mmol/L) | Na+ (mmol/L) | ATPase (U/107 cells) | 2,3-DPG (g/L) | Free Hb (mg/ml) |
Control | 61.68±2.69 | 18.58±8.76 | 7.44±0.17 | 1.43±0.48 | 148.71±2.74 | 0.078±0.022 | 9.67±1.74 | 0.089±0.005 |
Cisplatin (μg/ml) | ||||||||
50 | 59.58±1.61 | 19.36±8.45 | 7.43±0.14 | 1.96±0.51 | 152.58±5.63 | 0.069±0.020 | 8.92±1.12 | 0.091±0.005 |
100 | 58.95±5.20 | 21.86±7.09 | 7.37±0.14 | 2.11±0.54 | 153.55±3.87 | 0.063±0.017 | 8.47±1.16 | 0.094±0.004 |
200 | 58.47±4.76 | 16.91±6.20 | 7.26±0.09* | 2.42±0.67** | 154.91±6.84* | 0.055±0.016* | 7.63±1.22* | 0.098±0.006* |
HT60+cisplatin (μg/ml) | ||||||||
0 | 59.90±3.60 | 19.16±8.53 | 7.43±0.08 | 1.96±0.68 | 150.92±3.94 | 0.071±0.014 | 8.46±1.18 | 0.090±0.007 |
25 | 59.47±3.76 | 19.48±6.25 | 7.41±0.13 | 1.98±0.46 | 150.00±3.74 | 0.068±0.012 | 8.31±1.14 | 0.094±0.006 |
50 | 59.17±4.94 | 19.98±6.96 | 7.41±0.14 | 2.01±0.53 | 153.08±5.11 | 0.065±0.018 | 8.08±1.19 | 0.097±0.006 |
100 | 58.28±5.04 | 17.20±8.18 | 7.27±0.06* | 2.33±0.58* | 154.88±3.27* | 0.056±0.011* | 7.60±1.14* | 0.104±0.008** |
200 | 56.47±6.25 | 14.72±8.14 | 7.23±0.08** | 2.64±0.61** | 157.45±4.28** | 0.049±0.012** | 7.51±1.72* | 0.106±0.008** |
Data are expressed as mean±SD, with n=10 in each experiment
P<0.05 vs. control (treated at 37 °C for 60 min)
P<0.01 vs. control (treated at 37 °C for 60 min)